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In asthma, an important role for innate immunity is increasingly being recognized. Key innate immune cells in the lungs are
macrophages. Depending on the signals they receive,macrophages can at least have anM1,M2, orM2-like phenotype. It is unknown
how these macrophage phenotypes behave with regard to (the severity of) asthma. We have quantified the phenotypes in three
models of house dust mite (HDM-)induced asthma (14, 21, and 24 days). M1, M2, and M2-like phenotypes were identified by
interferon regulatory factor 5 (IRF5), YM1, and IL-10, respectively. We found higher percentages of eosinophils in HDM-exposed
mice compared to control but no differences between HDMmodels. T cell numbers were higher after HDM exposure and were the
highest in the 24-day HDM protocol. Higher numbers of M2 macrophages after HDM correlated with higher eosinophil numbers.
In mice with less severe asthma, M1 macrophage numbers were higher and correlated negatively with M2 macrophages numbers.
Lower numbers of M2-like macrophages were found after HDM exposure and these correlated negatively with M2 macrophages.
The balance between macrophage phenotypes changes as the severity of allergic airway inflammation increases. Influencing this
imbalanced relationship could be a novel approach to treat asthma.
1. Introduction
Asthma is characterized by irreversible obstruction and
chronic inflammation of the airways, and is traditionally
considered a T helper 2 (Th2-)cell driven inflammatory
disorder [1]. However, an important role for the innate
immune system in addition to the adaptive immune system
is increasingly being recognized in asthma [2].
Macrophages are key cells in innate immune responses
in the lung: they are among the most abundant cells and
one of the first to encounter allergens and other threats to
homeostasis.They also have the plasticity to quickly deal with
those without endangering normal gas exchange. Depending
on the signals received, macrophages can be pro- or anti-
inflammatory, immunogenic or tolerogenic, and destroying
or repairing tissue. Each characteristic may belong to a dif-
ferent macrophage phenotype with distinct functions [3, 4].
Tumor necrosis factor 𝛼 (TNF𝛼) and interferon 𝛾 (IFN𝛾)
induce, under the influence of the transcription factor
interferon-regulatory factor 5 (IRF5), a phenotype of M1
macrophageswith increasedmicrobicidal and/or tumoricidal
activities [4, 5]. Exposure to IL-4 or IL-13 results in a
population of M2 macrophages that is involved in anti-
parasite and tissue repair responses [6, 7]. In mice, these
cells are recognized by high production of chitinase and
chitinase-like molecules such as YM1 [7, 8]. A close sibling
of M2 macrophages is the M2-like macrophage phenotype.
These macrophages can be induced by a variety of stimuli
including exposure to aTLR-ligand in the presence of IL-10 or
manymore compounds.Themain characteristic of the subtly
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different M2-like population is the production of IL-10. Since
IL-10 is a potent anti-inflammatory cytokine, these M2-like
macrophages are effective inhibitors of inflammation [4].
Despite the broad the spectrum of macrophage activa-
tion, the role of macrophages in asthma has scarcely been
studied [9]. From what is known, all three macrophage
phenotypes have been implicated in the development of
murine and human asthma [10–12]. In mice, depending on
the protocol used, asthma phenotypes can greatly differ [13,
14].We aimed to investigate the distribution of the threemain
macrophages phenotypes in three different models of HDM-
induced asthma and also included the effects of sex on asthma
development. First, we show the general differences in airway
inflammation in the three HDM models and next we study
the distribution of the macrophage phenotypes with regard
to severity of allergic airway inflammation.
2. Materials and Methods
2.1. Animals. Male and female BALB/c mice (aged 6–8
weeks) were obtained fromHarlan (Horst,The Netherlands).
The mice were fed ad libitum with standard food and water
and were held under specific pathogen-free conditions in
groups of 4 mice per cage. The animal procedures, approved
by the Institutional Animal Care and Use Committee of
the University of Groningen (application number 5318),
were performed under strict governmental and international
guidelines.
2.2. House Dust Mite (HDM)-Induced Airway Inflammation
Models. Male (𝑛 = 4 per model) and female mice (𝑛 = 4
per model) were anaesthetized with isoflurane and exposed
intranasally to whole body HDM extract (Dermatophagoides
pteronyssinus, Greer laboratories, Lenoir, USA) in 40𝜇L
phosphate-buffered saline (PBS) according to three different
protocols. Control animals (𝑛 = 8) were exposed to 40 𝜇L
PBS according the 21-day protocol described.
Mice of the first model (𝑛 = 8) received 100 𝜇g HDM
extract intranasally on day 0, were subsequently exposed to
10 𝜇gHDMon day 7–11 according to the protocol of Hammad
et al. and were sacrificed on day 14 (abbreviated as 14-day
HDM) [15]. In the second model, according to Gregory et al.
[16], mice (𝑛 = 8) were exposed to 25 𝜇g HDM extract three
times a week during three weeks and were sacrificed on day
21 (abbreviated as 21-day HDM). For the last model (𝑛 = 7,
due to illness one female was excluded from the study), mice
were intranasally exposed to 100 𝜇g HDMon days 0, 7, 14 and
21 according to the protocol of Arora et al. andwere sacrificed
on day 24 (abbreviated as 24-day HDM) [17].
During sacrifice lungs were lavaged three times with
1mL cold PBS to determine the number of eosinophils and
YM1 levels. Then, the left lung lobe was collected to isolate
lung cells from digested lung for flow cytometry and the
right lung was inflated with 0.5mL 50% Tissue-Tek O.C.T.
compound (Sakura, Finetek Europe B.V., Zoeterwoude, The
Netherlands) in PBS and snap frozen/formalin-fixed for
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Figure 1: Experimental design of the study: three models of HDM-
induced allergic inflammation. HDM, house dust mite.
HDM-specific IgE levels. Figure 1 shows an overview of the
experimental designs.
2.3. HDM-Specific IgE. Serum levels of HDM-specific IgE
were measured by ELISA as described previously [18]. Arbi-
trary ELISA units of HDM-specific IgE titers were calculated
as relative values to the optical density of pooled sera from
HDM-exposed mice.
2.4. Bronchoalveolar Lavage Fluid (BALF). BALF was col-
lected and total numbers of cells were determined using a
Casy cell counter (Roche Innovatis AG, Reutlingen, Ger-
many). After centrifugation at 300×g for 10 minutes, BALF
supernatants were stored at −80∘C for further analysis (YM1
ELISA) and the cells were resuspended in RPMI medium
(BioWhittaker Europe, Verviers, Belgium) for preparation
of cytospots. Approximately 50,000 cells were spotted onto
slides using a cytospin 3 (Thermo Shandon, Waltham, MA,
USA) at 450 rpm for 5 minutes. To determine the percentage
of eosinophils in the cytospots, a Giemsa staining (Sigma-
Aldrich, Zwijndrecht, The Netherlands) was performed and
the number of eosinophils was counted in a total of 300 cells.
The level of mECF-L (YM1) in BALF supernatants was
determined by an ELISA kit according to the manufacturer’s
instructions (R&D Systems, Oxon, UK).
2.5. Lung Digestion. After bronchoalveolar lavage, the left
lung was minced and incubated in RPMI medium supple-
mented with 10% fetal calf serum (both Lonza, Verviers,
Mediators of Inflammation 3
Belgium), 10 𝜇g/mL DNAse I (grade II from bovine pan-
creas, Roche Applied Science, Almere, Netherlands), and
0.7mg/mL collagenase A (Sigma-Aldrich) for 45 minutes
at 37∘C in a shaking water bath. The digested lung tissue
was passed through a 70 𝜇m nylon strainer (BD Biosciences,
Breda,Netherlands) to obtain single cell suspensions. Incuba-
tion with 10 times diluted Pharmlyse (BD Biosciences, Breda,
The Netherlands) was performed to lyze contaminating
erythrocytes. Cells were centrifuged through 70 𝜇m strainer
caps and counted using a Casy cell counter (Roche Innovatis
AG). Cells were subsequently used for flow cytometry.
2.6. Flow Cytometric Analysis. The single lung cell sus-
pensions were stained for T-cell subsets using antibod-
ies for flow cytometry. Frequencies of effector T cells
(CD3+CD4+CD25+Foxp3−) and regulatory T cells (CD3+
CD4+CD25+Foxp3+) were examined using 𝛼CD3-APC/Cy7
(Biolegend, Fell, Germany), 𝛼CD4-PE/Cy7 (Biolegend),
𝛼CD25-PE (Biolegend), and 𝛼Foxp3-APC (eBioscience,
Vienna, Austria). An appropriate isotype control was used for
the Foxp3 staining (rat IgG2ak-APC, eBioscience).
Approximately 106 cells were incubated with the appro-
priate antibody mix including 1% normal mouse serum for
30 minutes on ice, protected from light. After washing the
cells with PBS supplemented with 2% FCS and 5mM EDTA,
the cells were fixed and permeabilized for 30 minutes using
a fixation and permeabilization buffer (eBioscience). Then
cells werewashedwith permeabilization buffer and incubated
with anti-Foxp3 including 1% normal mouse serum for 30
minutes. Subsequently, the cells were washed with perme-
abilization buffer, resuspended in FACS lysing solution (BD
Biosciences) and kept in the dark on ice until flow cytometric
analysis. The fluorescent staining of the cells was measured
on a LSR-II flow cytometer (BD Biosciences) and data were
analyzed using FlowJo Software (Tree Star, Ashland, USA).
2.7. Histology. Sections of 4 𝜇m were cut from the frozen
part of the right lung and stained for all macrophages
(rat 𝛼CD68, Serotec, Oxford, UK). The numbers of M2
macrophages were determined in frozen sections by staining
for YM1 (goat 𝛼-mECF-L, R&D Systems, Oxon, UK) using
standard immunohistochemical procedures. CD68 and YM1
were visualized with 3-amino-9-ethylcarbazole (AEC, Sigma
Aldrich, Zwijndrecht, The Netherlands).
The formalin-fixed part of the right lung was embedded
in paraffinthen sections of 3 𝜇m were cut. To identify the
M1 macrophages in tissue sections, antigen retrieval was
performed by overnight incubation in Tris-HCL buffer
pH 9.0 at 80∘C and then sections were stained for IRF5
(rabbit 𝛼-IRF5, ProteinTech Europe, Manchester UK)
using standard immunohistochemical procedures. To
determine the number of IL-10 producing cells, antigen
retrieval was performed by boiling the sections in citrate
buffer pH 6.0 for 10 minutes. The sections were pretreated
with 1% bovine serum albumin (Sigma Aldrich) and
5% milk powder in PBS for 30 minutes and incubated
with rabbit 𝛼-IL-10 overnight (Hycult Biotech, Uden,
The Netherlands). IRF5 and IL-10 were both visualized
with ImmPACT NovaRED kit (Vector, Burlingame, CA,
USA).
Positive cells were quantified by manual counting in
parenchymal lung tissue (thus excluding large airways, ves-
sels, and infiltrates, magnification 200–400x) and the total
tissue area was quantified by morphometric analysis using
ImageScope analysis software (Aperio, Vista, CA, USA). The
numbers of cells were expressed per mm2 of tissue.
2.8. Statistical Analysis. To determine if the data were nor-
mally distributed a Kolmogorov-Smirnov test was used.
If data sets were not normally distributed, appropriate
transformations were performed. The differences between
the models were tested using one-way analysis of vari-
ance (ANOVA) with Tukey’s post-hoc test for multiple
comparisons and sex differences were tested with the Stu-
dent’s t test. Pearson correlation coefficients were calcu-
lated to analyze the correlation between the inflammation
parameters and macrophages phenotypes, and correlations
withinmacrophage phenotypes (GraphPad Software, La Jolla,
CA, USA). Differences were considered significant when
𝑃 < 0.05, and 𝑃 < 0.10 was considered a statistical
trend.
3. Results
3.1. HDMExposure Induces Allergic Airway Inflammation. To
test whether exposure to HDM, according to three different
protocols, induced allergic airway inflammation differently,
we studied a number of general inflammation parameters.
Higher percentages of eosinophils in BALF were found in
all three HDM-exposed groups as compared to control mice
(Figure 2(a)). No differences in percentage of eosinophils
in BALF were observed between the three HDM proto-
cols. HDM-specific IgE levels in serum were not affected
by the different HDM exposures, only a trend of higher
levels was found in the group that was exposed to HDM
in the 21-day protocol. In all protocols of HDM expo-
sure, HDM-specific IgE levels were very low measuring
just above the limit of detection in the calibration curve
(Figure 2(b)).
The higher airway inflammation in the three HDM-
exposed groups was accompanied by higher percentages of
effector T cells in lung tissue as compared to the control
group (Figure 3(a)). The 24-day protocol showed a higher
percentage of effector T cells in lungs than the 14- and 21-day
protocol. After HDM exposure the percentage of regulatory
T cells was also higher in all three protocols as compared
to control mice (Figure 3(b)). The 24-day HDM protocol
induced higher percentages of regulatory T cells in lungs
compared to the 14-day protocol. The ratio of effector T cells
to regulatory T cells was higher in the 24-day HDM protocol
as compared to the control group and the other two HDM
protocols (Figure 3(c)).
In females, HDM exposure induced more eosinophilia
(𝑃 < 0.01), effector T cells (𝑃 < 0.05), regulatory T cells
(𝑃 < 0.05), and higher levels of HDM-specific IgE (𝑃 < 0.05)
than in males.





















































Figure 2: (a) HDM exposure induced higher percentages of eosinophils in BALF of males (♂) and females (♀) as compared to control, but
no differences were found between the HDM protocols. Combining all models, higher percentages of eosinophils after HDM exposure were
found in females as compared to males (𝑃 < 0.01). (b) The 21-day protocol increased HDM-specific IgE in serum of male and female mice
as compared to control (trend, 𝑃 < 0.1). Again combining all models, HDM exposure induced higher levels of HDM-specific IgE in females
than in males (𝑃 < 0.05). ###𝑃 < 0.001 compared to control.
3.2. HDM Exposure Induces M1 and M2 Macrophages but
Inhibits M2-Like Macrophages. To study the presence of
macrophage phenotypes after HDM exposure according to
the three different protocols, we stained lung tissue for
markers of total macrophages (CD68), M1 macrophages
(IRF5), M2 macrophages (YM1), and M2-like macrophages
(IL-10) and counted positive cells in parenchymal tissue.
HDM-exposed mice had more CD68-positive cells in
lung tissue as compared to control mice (Figure 4(a)).
No differences in CD68-positive numbers were observed
between the HDM protocols. Compared to control mice,
IRF5-positive cell numbers were higher in 14- and 21-
day protocol, but not in mice exposed to HDM according
to the 24-day protocol (Figure 4(b)). Between the HDM
models, lower IRF5-positive numbers were found in lungs
of mice that were exposed to HDM according to the 24-
day protocol as compared to the mice of the 14-day HDM
protocol.
For YM1, all HDM protocols induced more YM1-positive
cells as compared to control (Figure 4(c)). However, mice
that were exposed in the 24-day HDM protocol had higher
numbers of YM1-positive cells in lung tissue than the mice of
the 14-day HDM protocol. YM1 levels in BALF were elevated
in all HDMmodels as compared to control, but no differences
were found between the models (Figure 5). Interestingly,
HDM exposure resulted in significantly lower numbers of
IL-10-positive cells in all three protocols compared to the
control-treated group (Figure 4(d)). There were no differ-
ences observed in IL-10-positive cell numbers between the
three HDM protocols.
HDM-exposed females had more CD68-positive cells
(𝑃 < 0.05), YM1-positive cells (𝑃 < 0.01), and higher levels
of BALF YM1 (𝑃 < 0.05) than males, whereas no differences
were found in IRF5- and IL-10-positve cells numbers between
the two sexes.
3.3. M2 Macrophages Positively Correlate with Parameters
of Airway Inflammation. To assess how severity of airway
inflammation is reflected by the presence of the three main
macrophage phenotypes, we correlated parameters of allergic
airway inflammation with the different macrophage pheno-
types in HDM-exposed mice (Table 1).
Numbers of CD68-positive cells correlated positively
with the percentage of eosinophils in BALF (𝑟 = 0.58),
effector T cells (trend, 𝑟 = 0.37) and regulatory T cells
(𝑟 = 0.42) in lungs of HDM-exposed mice, indicating that
more severe disease was accompanied bymore macrophages.
Most of thesemacrophages appear to be YM1-positive as only
YM1-positive cell numbers correlated significantly with the
percentage of eosinophils in BALF (𝑟 = 0.48, Figure 6) and
the percentage of regulatory T cells (𝑟 = 0.51) in lung tissue.
No differences were found between males and females.
3.4. M2 Macrophages Negatively Correlate with IRF5-Positive
and IL-10-Positive Cells. To study the relationship between
the different macrophage phenotypes in allergic airway
inflammation, correlations were made between YM1-postive,
IRF5-positive, IL-10-positive, andCD68-positive cells in lung
tissue of all HDM-exposed mice (Table 2).
Numbers of IRF5-positive cells negatively correlated with
cells positive for CD68 (trend, 𝑟 = −0.40) and YM1 in lung
tissue (𝑟 = −0.70, Figure 7(a)). YM1-positive cell numbers
correlated negatively with numbers of IL-10-positve cells (𝑟 =
−0.48, Figure 7(b)) and positively with numbers of CD68-
positive cells in lung tissue (𝑟 = 0.66). No differences were
found between males and females.
4. Discussion
Our study has shown that the balance between macrophage
phenotype changes as the severity of allergic inflamma-
tion increases. Higher numbers of M2 macrophages in
































































































Figure 3: (a) HDMexposure induced higher percentages of effector T cells in lung tissue ofmales (♂) and females (♀) as compared to control.
Higher percentages of effector T cells were found in the 24-day protocol as compared to the 14- and 21-day protocol of HDM exposure.
Combining all models, HDM exposure induced higher percentages of effector T cells in females than in males (𝑃 < 0.05). (b) HDM exposure
induced higher percentages of regulatory T cells in lung tissue of males and females as compared to control. Higher percentages of regulatory
T cells were found in the 24-day protocol as compared to the 14-day protocol of HDM exposure. Combining all models, HDM exposure
induced higher percentages of regulatory T cells in females than in males (𝑃 < 0.05). (c) The 24-day protocol had higher ratios of effector
T cells to regulatory T cells in lung tissue of males and females as compared to control and the 14- and 21-day protocols of HDM exposure.
Combining all models, no differences were found between males and females. #𝑃 < 0.05, ##𝑃 < 0.01 and ###𝑃 < 0.001 compared to control.
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01 and ∗∗∗𝑃 < 0.001.
HDM-exposed mice correlated with higher percentages of
eosinophils in BALF. At the same time lower numbers of M1
macrophages and M2-like macrophages were found in the
mice with more severe inflammation and these therefore cor-
related negatively withM2macrophages. In addition, we have
confirmed again that females have more pronounced airway
inflammation with higher numbers of M2 macrophages as
compared to males [19].
The models we used for our study were short-term
exposure to HDM and they give us much information about
the distribution of the different macrophage phenotypes
during induction of asthma. In these models we found
that longer exposure to HDM did not induce more severe
eosinophilic inflammation but it did lead to higher num-
bers of M2 macrophages and higher percentages of effector
and regulatory T cells in lungs of mice. The fact that we
found no differences in eosinophils between the models
is probably due to the large variation within the groups.
However, when analyzing all HDM-exposed mice separately,
eosinophils correlated positively with total macrophages
and M2 macrophages, confirming our previous findings
in humans that M2 macrophages increase with increasing
asthma severity [20]. Another important parameter of aller-
gic airway inflammation, serum HDM-specific IgE, could























































































































Figure 4: (a) HDM-exposed male (♂) and female (♀) mice had more CD68-positive cells in lung tissue as compared to control, but no
differences were found between the HDM protocols. Combining all models, HDM exposure induced higher numbers of CD68-positive cells
in females than in males (𝑃 < 0.05). (b) HDM-exposed male and female mice had more IRF5-positive cells in lung tissue as compared to
control, but no differences were found between males and females when combining all models. The 14-day HDM protocol induced higher
numbers of IRF5-positive cells as compared to the 24-day HDM protocol. (c) HDM-exposed male and female mice had more YM1-positive
cells in lung tissue as compared to control, with higher numbers of YM1-positive cells in females than in males (𝑃 < 0.01). The 24-day HDM
protocol induced higher numbers of YM1-positive cells as compared to the 14-day HDM protocol. (d) HDM-exposed male and female mice
had lower numbers of IL-10-positive cells in lung tissue as compared to control, but no differences were found between the HDM protocols
and between the sexes. The middle and right-hand panels are representative photos of control and HDM-exposed mice for all four stainings
(magnification 200x). #𝑃 < 0.05, ##𝑃 < 0.01 and ###𝑃 < 0.001 compared to control. ∗𝑃 < 0.05.
























Figure 5: HDM exposure induced higher levels ofYM1 in bron-
choalveolar lavage fluid (BALF) of male (♂) and female (♀) mice
as compared to control, but no differences were found between the
HDM protocols. Combining all models, HDM exposure induced
higher levels of YM1 in BALF in females than in males (𝑃 < 0.05).
#
𝑃 = 0.05 and ###𝑃 < 0.001 compared to control.
Table 1: Correlations between macrophage phenotype markers and









Eosinophils 0.58∗∗ −0.26 0.48∗ 0.01
HDM-specific IgE −0.06 −0.18 0.33 −0.13
Effector T cells 0.37# −0.30 0.29 0.05
Regulatory T cells 0.42∗ −0.20 0.51∗ −0.21
Values are correlations coefficients (Pearson correlation). #P < 0.1, ∗P < 0.05
and ∗∗P < 0.01.
Table 2: Correlations between macrophage phenotype markers.
CD68+ cells IRF5+ cells YM1+ cells IL-10+ cells
CD68+ cells −0.40# 0.66∗∗ −0.17
IRF5+ cells −0.70∗∗ 0.20
YM1+ cells −0.48∗
Values are correlations coefficients (Pearson correlation). #P < 0.1, ∗P < 0.05
and ∗∗P < 0.01.
barely be detected probably because the duration of the
models was too short. It takes around 3 weeks for naive B cells
to mature to plasma cells and switch from IgM production to
IgE after first contact with an antigen [21]. Our models lasted
24 days at the most and we therefore sacrificed our animals
before a full-blown IgE response could develop. Also, studies
from other groups using these models did not show HDM-
specific IgE in serum [15–17]. To investigate howmacrophage
phenotypes are distributed during and contribute to more
chronic disease, longer models of HDM-exposure need to be
used.
We sought to phenotype the distinct macrophage subsets
in lung tissue using markers that could distinguish each
phenotype. We identified M2 macrophages using expression
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Figure 6: YM1-positive cell numbers (cells/mm2 lung tissue) cor-
related with percentage of eosinophils in BALF of male and female
mice exposed to HDM according to three different protocols. No
differences were found betweenmales and females when combining
all models.
Previous studies found that only macrophages express YM1
and the staining is not complicated by other cells stain-
ing positive [22–24]. A unique marker for identifying M1
macrophages in lung tissue is, however, more difficult to
find. To our knowledge selective surface markers for tissue
are not available and therefore the production of IL-12 and
oxygen radicals have been used in several mouse studies
[25, 26]. In asthma, oxygen radicals cannot be used to
stain for M1 macrophages because these are also copiously
produced by eosinophils that are present in great numbers
[27]. Recently, IRF5 was found to be the transcription factor
controlling M1 differentiation. It is highly expressed in M1
macrophages while it suppresses the M2 phenotype [5].
Our study was the first to use IRF5 as an M1 marker on
lung tissue and it is a fairly selective marker. Bronchial
epithelial cells and incoming leukocytes in infiltrates also
stain positive for IRF5 but these could be excluded from the
quantification of parenchymal tissue based on localization. A
double staining with CD68 to make sure only macrophages
are included in the quantification is unfortunately at present
not possible due to technical incompatibilities. In previous
studies, M2-like macrophages are often not distinguished
from M2 macrophages because they share many mark-
ers, including mannose receptors. The production of the
immunosuppressive cytokine IL-10 is the most important
and reliable characteristic of M2-like macrophages and can
be used to identify these cells with [4]. Similar to IRF5,
bronchial epithelial cells and some cells in infiltrates are also
expressing IL-10 but these can easily be excluded from the
quantification of parenchymal tissue. To exclude other IL-
10-producing cells from the analysis a double staining with
CD68 is needed, but at present also not possible. These
limitations in the stainings for IRF5 and IL-10 may also
explain why the total number of YM1-, IRF5- and IL-10-
positive cells is higher than the number of CD68-positive
cells.
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Figure 7: (a) YM1-positive cell numbers correlated with IRF5-positive cell numbers in lung tissue of male and female mice exposed to HDM
according to 3 different protocols. (b) YM1-positive cells numbers correlated with IL-10-positive cell numbers in lung tissue of male and
female mice exposed to HDM according to three different protocols. No differences were found between males and females when combining
all models.
Higher numbers of M2macrophages were found in lungs
of HDM-exposed mice, which correlates with previous stud-
ies [19, 20, 28]. Interestingly, numbers of M2 macrophages
and the levels of YM1 in BALF correlated strongly with
eosinophils in BALF. YM1 is also known as eosinophil
chemotactic factor (ECF-L) [29], but it was suggested that
YM1 only has weak chemotactic properties for eosinophils
[24, 30].The chemotactic strength of YM1 is still debated and
our findings and those of others do suggest otherwise [23,
31]. The number of M2 macrophages also showed a positive
correlation with regulatory T cells. In an interesting study by
Tiemessen et al., regulatoryT cells were shown to promote the
induction ofM2macrophages to help with trying tomaintain
tissue homeostasis and preventing toomuch tissue damage of
the inflammatory response [32]. Our data could be explained
along these lines with incoming regulatory T cells inducing
M2 macrophages in an attempt to restrict inflammation and
tissue damage induced byHDM.TheM2macrophages would
then be the result of inflammation and be beneficial instead
of contributing to allergic airway inflammation, which is still
an ongoing debate [19, 33, 34].
Asthma is dominated by a Th2-driven inflammation,
but evidence shows that M1 macrophages are also present
in this disease. In two interesting studies, IFN𝛾-stimulated
macrophages were shown to prevent the onset of allergic
airway inflammation [35, 36]. Our findings with higher num-
bers of M1 macrophages in the shorter protocols and in less
severe diseases suggest that these macrophages are induced
as a counterregulatory mechanism to dampen inflammation.
However, higher numbers of M1 macrophages in asthma
have also been shown in severe asthma and markers of M1
macrophages correlate with asthma severity, suggesting that
M1 macrophages play a role in severe asthma as well [37–
39]. This appears not to be the case for our results because
we find higher numbers of M1 macrophages at the onset of
allergic airway inflammation when numbers of effector T
cells are lower, and lower numbers of M1 macrophages in
the 24-day HDM protocol when effector T-cell numbers are
higher. M1 macrophages appear to have a beneficial role in
preventing allergic sensitization, but in already established
disease they promote the development of a severe phenotype.
A similar double role has been reported for the M1 cytokine
IL-12 in allergic airway inflammation [40]. Since our HDM
models are short and focus on the onset of the disease, we do
not have information on the presence of M1 macrophages in
established, more severe disease.
Since M2-like macrophages have anti-inflammatory
functions, we were interested in the presence of this
macrophage phenotype in HDM-induced asthma. Others
have reported that interstitial macrophages are the IL-10-
producing macrophages and treatment of sensitized mice
with these macrophages prevented the development of aller-
gic airway inflammation [41]. Our observation of lower
numbers of M2-like macrophages in asthma as compared to
control is in line with these and previous findings in human
asthmatics [42, 43]. Interestingly, it was shown that IL-10
production in severe asthmatics is even lower as compared to
moderate asthmatics and that treatment with corticosteroids
induces IL-10 production by macrophages [43, 44]. This
suggests that specific stimulation of macrophages to polarize
to M2-like macrophages that produce IL-10 may reduce
asthma symptoms.
Women suffer from more severe asthma than men and
this phenomenon was also found in mouse models of asthma
[45, 46]. A role for sex hormones has been suggested, but
the underlyingmechanisms are unknown [47]. In accordance
with the previous findings, we show that HDM-exposed
femalemice hadmore pronounced airway inflammation than
male mice. In macrophage phenotypes, we only found a
difference in theM2macrophages. Since we and others found
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a correlation between M2 macrophages and asthma severity,
it may suggest that this phenotype could play a role in the
increased airway inflammation in females [19].
5. Conclusion
Taken together, our data suggest that during the development
of allergic airway inflammation M1 and M2 macrophages
are induced or recruited, whereas M2-like macrophages are
prevented from moving in or inhibited. As HDM-induced
inflammation progresses, M1 macrophages are diminished
in favor of M2 macrophages possibly under the influence
of regulatory T cells that try to restrict inflammation. Their
work may be hampered by the fact that IL-10-producing
M2-like macrophages do not develop in HDM-induced
inflammation and the inflammation can progress. Influenc-
ing this imbalanced relationship by therapeutic macrophage
targeting could be a novel way to treat asthma.
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